Apollo Health Ventures is an early-stage life science investment firm dedicated to accelerating the development of breakthrough scientific discoveries into clinical applications. The firm focuses on building companies around new therapeutic technologies aimed at treating, preventing, or reversing age-related diseases such as Alzheimer's, Heart Disease, Sarcopenia, Frailty, and Cancer. Apollo typically invests in seed and Series A rounds, supporting startups that have the potential to significantly increase healthy human lifespan.